News | PACS | July 31, 2017

RamSoft Joins Forces with Availity to Offer Automated Authorization and Upfront Patient Collection Solutions

RamSoft has teamed up with Availity to bring healthcare providers Patient Access and Patient Authorizations

RamSoft has teamed up with Availity to bring healthcare providers Patient Access and Patient Authorizations, two fully integrated solutions that seamlessly automate authorizations and optimize up-front collections. These tools integrate with RamSoft’s PowerServer RIS/PACS and TELE PLUS to lower administrative overhead, maximize yield, and eliminate manual and redundant processes.

“As we move to value-based care, providers continue to face challenges with efficiencies and reimbursement,” said Russ Thomas, CEO, Availity. “I’m thrilled when we can align our Authorizations and Patient Access solutions with vendors like RamSoft to collaboratively address these challenges head on, and help providers succeed in the changing marketplace landscape.”

"Working with Availity, we will be able to help our customers increase upfront collections from patients and significantly decrease prior authorization costs. This is really a must for our customers to thrive amidst declining reimbursements," said Vijay Ramanathan, CEO, RamSoft Inc.

According to the 2016 CAQH Index study, authorizations are among the least automated transactions in healthcare, with 82 percent processed manually. Automating these manual processes with Availity’s Patient Authorizations reduces costs, decreases denials, and eliminates the need for multiple systems; which increases patient and referring provider satisfaction and streamlines staff workflow.

Patient Access accurately estimates patient responsibility (pre-service) to maximize collections and ensure the best possible patient experience. It enables frontline employees to verify insurance, medical necessity, address, and identity in real-time; process payments; follow customized, online scripting tailored for each healthcare provider and patient type; generate meaningful analytics; and calculate contracts for estimating appropriate charges for deductible, co-pay, and coinsurance.

For more information: www.ramsoft.com

Related Content

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

News | Coronavirus (COVID-19) | July 09, 2020
July 9, 2020 — With increased lung CT exam paradigms being used in the current...
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
Sponsored Content | Videos | PACS | June 29, 2020
Kevin Borden, Vice President of Product, Healthcare IT for Konica Minolta, talks about Improving Access and Aiding Wo
n support of Mayo Clinic’s digital health and practice transformation initiatives, the Mayo Clinic Department of Laboratory Medicine and Pathology has initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and management system to enable digital pathology. 
News | Enterprise Imaging | June 26, 2020
June 26, 2020 —  In support of Mayo Clinic’s digital health
Visage announces cloud implementation, Visage 7 Workflow and semantic annotations
News | Enterprise Imaging | June 26, 2020
June 26, 2020 — Visage Imaging, Inc.
he FDA launched the first “FDA Insight” podcast, featuring FDA Commissioner Stephen Hahn, M.D., and FDA Deputy Commissioner for Medical and Scientific Affairs Anand Shah, M.D., discussing FDA's COVID-19 efforts, including the drug development process for a COVID-19 treatment.

Getty Images

News | Coronavirus (COVID-19) | June 25, 2020
June 25, 2020 — The FDA launched the first “...